1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Baloxavir marboxil
Trade Name:
Xofluza
Manufacturer/Distributor:
Hoffman-La Roche Limited
Classification:
Antiviral agent
ATC Class:
J05AX25 - baloxavir marboxil
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/02/19
Date Marketed in Canada (yyyy/mm/dd):
2020/02/19
Presentation:
Tablet: 20 mg. DIN: 02496364
Tablet: 40 mg. DIN: 02496372
Comments:
For treatment of uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours and who are otherwise healthy or at high risk of developing influenza complications.
Back to:
Drug Product Listings 
